Union Pacific (UNP) Offering Possible 30.55% Return Over the Next 35 Calendar Days

Union Pacific's most recent trend suggests a bullish bias. One trading opportunity on Union Pacific is a Bull Put Spread using a strike $210.00 short put and a strike $200.00 long put offers a potential 30.55% return on risk over the next 35 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $210.00 by expiration. The full premium credit of $2.34 would be kept by the premium seller. The risk of $7.66 would be incurred if the stock dropped below the $200.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Union Pacific is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Union Pacific is bullish.

The RSI indicator is at 71.71 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Union Pacific

Union Pacific (UNP) to Report Q3 Earnings: What's in Store?
Thu, 14 Oct 2021 07:06:07 +0000
Higher fuel price per gallon is likely to have limited Union Pacific's (UNP) bottom-line growth in Q3.

UPDATE 1-Union Pacific to comply with COVID vaccine deadline for U.S. workers
Wed, 13 Oct 2021 20:57:19 +0000
Union Pacific Corp said on Wednesday it will require its 31,000 U.S. employees to be vaccinated under President Joe Biden's executive order requiring that federal contractors mandate vaccines by Dec. 8, except for employees who receive an approved exemption. “As a federal contractor who ships goods supporting our nation's armed services, … all employees are required to report their vaccination status or have an approved medical or religious accommodation by the federally mandated deadline,” Union Pacific, the top U.S. railroad operator, said in a statement. Last month, U.S. passenger railroad Amtrak said it will require nearly all of its 18,000 employees be fully vaccinated for COVID-19 by Nov. 22.

Union Pacific to comply with COVID vaccine deadline for U.S. workers
Wed, 13 Oct 2021 20:06:43 +0000
WASHINGTON (Reuters) -Union Pacific Corp said on Wednesday it will require its 31,000 U.S. employees to be vaccinated under President Joe Biden's executive order requiring that federal contractors mandate vaccines by Dec. 8, except for employees who receive an approved exemption. “As a federal contractor who ships goods supporting our nation's armed services, … all employees are required to report their vaccination status or have an approved medical or religious accommodation by the federally mandated deadline,” Union Pacific, the top U.S. railroad operator, said in a statement. Last month, U.S. passenger railroad Amtrak said it will require nearly all of its 18,000 employees be fully vaccinated for COVID-19 by Nov. 22.

This crazy shipping crisis, explained
Sat, 09 Oct 2021 11:50:13 +0000
No doubt you’ve heard how the world’s supply chain is being stressed like never before. What we are witnessing is a massive, unprecedented traffic jam of humankind's largest sea vessels that is at the very core of the conundrum.

3 Stocks Immune to America's Port Crisis
Sat, 09 Oct 2021 11:00:00 +0000
Here's why three Fools expect Union Pacific (NYSE: UNP), Eagle Bulk Shipping (NASDAQ: EGLE), Costamare (NYSE: CMRE) to power through this shipping crisis. Union Pacific shares have gone nowhere in the last year, and the stock is trailing the S&P 500 by more than 20 percentage points over the past three years.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.